JP2025010171A5 - - Google Patents

Download PDF

Info

Publication number
JP2025010171A5
JP2025010171A5 JP2024184185A JP2024184185A JP2025010171A5 JP 2025010171 A5 JP2025010171 A5 JP 2025010171A5 JP 2024184185 A JP2024184185 A JP 2024184185A JP 2024184185 A JP2024184185 A JP 2024184185A JP 2025010171 A5 JP2025010171 A5 JP 2025010171A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024184185A
Other languages
Japanese (ja)
Other versions
JP2025010171A (ja
Filing date
Publication date
Priority claimed from JP2022551031A external-priority patent/JP2023511780A/ja
Application filed filed Critical
Publication of JP2025010171A publication Critical patent/JP2025010171A/ja
Publication of JP2025010171A5 publication Critical patent/JP2025010171A5/ja
Pending legal-status Critical Current

Links

JP2024184185A 2020-02-25 2024-10-18 コロナウイルスに対するワクチンおよび使用方法 Pending JP2025010171A (ja)

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
US202062981451P 2020-02-25 2020-02-25
US202062981168P 2020-02-25 2020-02-25
US62/981,451 2020-02-25
US62/981,168 2020-02-25
US202063004380P 2020-04-02 2020-04-02
US63/004,380 2020-04-02
US202063022032P 2020-05-08 2020-05-08
US63/022,032 2020-05-08
US202063028404P 2020-05-21 2020-05-21
US63/028,404 2020-05-21
US202063033349P 2020-06-02 2020-06-02
US63/033,349 2020-06-02
US202063040865P 2020-06-18 2020-06-18
US63/040,865 2020-06-18
US202063046415P 2020-06-30 2020-06-30
US63/046,415 2020-06-30
US202063056996P 2020-07-27 2020-07-27
US63/056,996 2020-07-27
US202063063157P 2020-08-07 2020-08-07
US202063062762P 2020-08-07 2020-08-07
US63/063,157 2020-08-07
US63/062,762 2020-08-07
US202063114858P 2020-11-17 2020-11-17
US63/114,858 2020-11-17
US202063130593P 2020-12-24 2020-12-24
US63/130,593 2020-12-24
US202163136973P 2021-01-13 2021-01-13
US63/136,973 2021-01-13
JP2022551031A JP2023511780A (ja) 2020-02-25 2021-02-25 コロナウイルスに対するワクチンおよび使用方法
PCT/US2021/019662 WO2021173829A1 (en) 2020-02-25 2021-02-25 Vaccines against coronavirus and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022551031A Division JP2023511780A (ja) 2020-02-25 2021-02-25 コロナウイルスに対するワクチンおよび使用方法

Publications (2)

Publication Number Publication Date
JP2025010171A JP2025010171A (ja) 2025-01-20
JP2025010171A5 true JP2025010171A5 (enExample) 2025-06-17

Family

ID=75108858

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022551031A Withdrawn JP2023511780A (ja) 2020-02-25 2021-02-25 コロナウイルスに対するワクチンおよび使用方法
JP2024184185A Pending JP2025010171A (ja) 2020-02-25 2024-10-18 コロナウイルスに対するワクチンおよび使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022551031A Withdrawn JP2023511780A (ja) 2020-02-25 2021-02-25 コロナウイルスに対するワクチンおよび使用方法

Country Status (15)

Country Link
US (3) US11660335B2 (enExample)
EP (1) EP4110468A1 (enExample)
JP (2) JP2023511780A (enExample)
KR (1) KR20220157969A (enExample)
CN (1) CN115867349A (enExample)
AU (2) AU2021226567B2 (enExample)
BR (1) BR112022016507A2 (enExample)
CA (1) CA3168353A1 (enExample)
CO (1) CO2022012272A2 (enExample)
CU (1) CU24743B1 (enExample)
IL (1) IL295697A (enExample)
MX (1) MX2022010460A (enExample)
PE (1) PE20230171A1 (enExample)
PH (1) PH12022552249A1 (enExample)
WO (1) WO2021173829A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021252604A1 (en) * 2020-06-09 2021-12-16 The Wistar Institute Of Anatomy And Biology Coronavirus disease 2019 (covid-19) combination vaccine
WO2021249116A1 (en) 2020-06-10 2021-12-16 Sichuan Clover Biopharmaceuticals, Inc. Coronavirus vaccine compositions, methods, and uses thereof
WO2022236301A1 (en) * 2021-05-05 2022-11-10 Inovio Pharmaceuticals Inc. Vaccines against coronavirus and methods of use
US20240270828A1 (en) * 2021-09-03 2024-08-15 The Uab Research Foundation Human neutralizing antibodies against sars-cov-2 spike s2 domain and uses thereof
WO2023073672A1 (en) * 2021-10-29 2023-05-04 Geneone Life Science, Inc. Therapeutic and vaccine candidates against sars-cov-2
WO2024231886A1 (en) * 2023-05-10 2024-11-14 Seqirus Inc. Combination vaccine

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US21579A (en) 1858-09-21 Rotary valve fob steam-engines
US3805783A (en) 1971-02-12 1974-04-23 A Ismach Hand powered hypodermic jet injector gun
US4342310A (en) 1980-07-08 1982-08-03 Istvan Lindmayer Hydro-pneumatic jet injector
US4447223A (en) 1982-04-16 1984-05-08 Cct Associates Medicament implant applicator
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5843463A (en) 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5545130A (en) 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
AU4528493A (en) 1992-06-04 1994-01-04 Regents Of The University Of California, The In vivo gene therapy with intron-free sequence of interest
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5505697A (en) 1994-01-14 1996-04-09 Mckinnon, Jr.; Charles N. Electrically powered jet injector
US5869326A (en) 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
US6241701B1 (en) 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
US6216034B1 (en) 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US6120493A (en) 1998-01-27 2000-09-19 Genetronics, Inc. Method for the introduction of therapeutic agents utilizing an electroporation apparatus
US6009347A (en) 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6208893B1 (en) 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
AU761522B2 (en) 1998-07-13 2003-06-05 Genetronics, Inc. Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications
US6192270B1 (en) 1998-08-14 2001-02-20 Genetronics, Inc. Apparatus and method for the delivery of drugs and genes into tissue
US6150148A (en) 1998-10-21 2000-11-21 Genetronics, Inc. Electroporation apparatus for control of temperature during the process
WO2000067837A1 (en) 1999-05-10 2000-11-16 Gentronics, Inc. Method of electroporation-enhanced delivery of active agents
US7171264B1 (en) 1999-05-10 2007-01-30 Genetronics, Inc. Intradermal delivery of active agents by needle-free injection and electroporation
US7245963B2 (en) 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
US7328064B2 (en) 2002-07-04 2008-02-05 Inovio As Electroporation device and injection apparatus
US20050025788A1 (en) * 2003-06-06 2005-02-03 Chou George Chin-Sheng Systemic delivery of non-viral vector expressing SARS viral genomic vaccine
KR20230122181A (ko) * 2013-11-29 2023-08-22 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 중동 호흡기 증후군 코로나바이러스(MERS-CoV) 백신
US10953089B1 (en) 2020-01-27 2021-03-23 Novavax, Inc. Coronavirus vaccine formulations
TW202204380A (zh) 2020-01-31 2022-02-01 美商詹森藥物公司 用於預防及治療冠狀病毒感染之組合物及方法-sars-cov-2疫苗
US10906944B2 (en) 2020-06-29 2021-02-02 The Scripps Research Institute Stabilized coronavirus spike (S) protein immunogens and related vaccines

Similar Documents

Publication Publication Date Title
JP2025010171A5 (enExample)
CN308409207S (enExample)
CN308408428S (enExample)
CN308403528S (enExample)
CN308403558S (enExample)
CN308403571S (enExample)
CN308403592S (enExample)
CN308403755S (enExample)
CN308403838S (enExample)
CN308403861S (enExample)
CN308403931S (enExample)
CN308403996S (enExample)
CN308404035S (enExample)
CN308404310S (enExample)
CN308404312S (enExample)
CN308404348S (enExample)
CN308404410S (enExample)
CN308404420S (enExample)
CN308404435S (enExample)
CN308404466S (enExample)
CN308404595S (enExample)
CN308404613S (enExample)
CN308404658S (enExample)
CN308406041S (enExample)
CN308407549S (enExample)